Shenlian Decoction Ameliorates LPS-Related Inflammation in db/db Mice: Coupling Network Pharmacology With Experimental Verification
Conclusions: This research investigated the multigene pharmacological mechanism of SL decoction against T2DM using network pharmacology and in vivo experiments. SL decoction treatment of T2DM may reverse inflammation by inhibiting LPS-related pathway activation and improving intestinal function.
Saved in:
Main Authors: | Yi-fan Liu, Yuan-yuan Liu, Yao Xiao, Wei-jun Huang, Rui-xi Sun, Jie Hu, Xiao-zhe Fu, Chu-xiao Tian, Qiang Fu, Jin-xi Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/jdr/3823051 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shenlian (SL) Decoction, a Traditional Chinese Medicine Compound, May Ameliorate Blood Glucose via Mediating the Gut Microbiota in db/db Mice
by: Rui-xi Sun, et al.
Published: (2022-01-01) -
Gut Microbiota Composition and Structure of the Ob/Ob and Db/Db Mice
by: Mingsheng Yang, et al.
Published: (2019-01-01) -
Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
by: Xiao-Wen Chen, et al.
Published: (2016-01-01) -
Impaired Muscle Regeneration in Ob/ob and Db/db Mice
by: Mai-Huong Nguyen, et al.
Published: (2011-01-01) -
Pyruvate-Enriched Oral Rehydration Solution Improves Glucometabolic Disorders in the Kidneys of Diabetic db/db Mice
by: Xiao Meng Zhang, et al.
Published: (2020-01-01)